SLC43A3 activators refer to a group of chemical compounds that are designed to upregulate the activity of the SLC43A3 protein, which is part of the solute carrier (SLC) family of membrane transport proteins. SLC43A3, specifically, is implicated in the facilitated transport of certain molecules across cellular membranes, playing a role in the cellular uptake of substrates that are crucial for various metabolic processes. The precise physiological substrates and full spectrum of functions of SLC43A3 remain an area of active research, but it is understood that enhancing its activity could have implications for the modulation of intracellular concentrations of its substrates. SLC43A3 activators, therefore, are of interest in the study of cellular transport mechanisms and metabolic regulation, providing a means to influence the internal cellular environment in a targeted manner.
The discovery and optimization of SLC43A3 activators typically involve a combination of high-throughput chemical screening, medicinal chemistry, and computational modeling. Screening assays are used to identify initial lead compounds that can interact with SLC43A3 and increase its transport activity. These leads can then be chemically modified to improve their efficacy, selectivity, and pharmacokinetic properties. Structure-activity relationship (SAR) studies play a crucial role in this optimization process, as they allow scientists to systematically vary the chemical structure of lead compounds and evaluate the resulting changes in their biological activity. Computational methods, including molecular docking and dynamics simulations, are also invaluable for predicting how potential activators might interact with the SLC43A3 protein at a molecular level, thereby informing the design of more potent and specific activators.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid may upregulate SLC43A3 by binding to retinoic acid receptors, initiating transcriptional changes in the liver and thyroid. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol could stimulate SLC43A3 transcription by engaging estrogen receptors, particularly in tissues with high hormone sensitivity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which may prompt an increase in SLC43A3 expression through the activation of cAMP-responsive elements. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin might promote the expression of SLC43A3 by triggering insulin signaling pathways that lead to transcriptional activity in the liver. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone is proposed to stimulate SLC43A3 expression in hepatic cells via glucocorticoid receptor-mediated transcriptional activation. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol can upregulate SLC43A3 by engaging vitamin D receptors, thereby initiating transcriptional responses in various tissues. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has the potential to enhance SLC43A3 expression by initiating antioxidant response element-mediated transcription in the liver. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may increase SLC43A3 expression by inhibiting histone deacetylases, resulting in a more accessible chromatin state for transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may induce SLC43A3 expression by activating transcription factors such as NF-κB, influencing transcription in multiple tissues. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone is known to stimulate SLC43A3 expression through glucocorticoid receptor-mediated mechanisms, particularly in glucocorticoid-responsive tissues. | ||||||